The largest database of trusted experimental protocols

7 protocols using nf κb p65 sc 8008

1

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
RIPA buffer (150 mMNaCl, 10 mM Tris, pH 7.2, 0.1% SDS, 1.0% Triton X-100, 5 mM EDTA, pH 8.0) containing a protease inhibitor cocktail (Roche Applied Science, USA) and a phosphatase (Sigma-Aldrich) inhibitor cocktail was used to obtain the cell lysates. Protein concentration was determined using Bradford Reagent (Sigma-Aldrich, Milano, Italy). Total protein extracts (25 μg) were separated by SDS-PAGE and then transferred to a nitrocellulose membrane using the Trans-Blot Turbo™ Transfer system (Bio-Rad). Membranes were then blocked for 1 h at room temperature (RT) in TBS with 0.1% of Tween-20 containing 5% non-fat dried milk, and subsequently incubated overnight at 4 °C with the primary antibodies of interest. All primary antibodies were probed with a secondary horseradish peroxidase (HRP)-conjugated antibody (Vector, USA). Proteins were visualized by ECL and the chemiluminescent signaling acquired using ChemiDoc XRS + System (Bio-RadLaboratories, Hercules, CA, USA) and analyzed using Image J software (Version 1.50i, National Institute of Health, Bethesda, MD, USA).
The primary antibodies used were Caspase-3 (CAS3) (# 9664) (Cell Signaling Tecnologies), Phospho-NF-κB p65 (# 5970), NF-κB p65 (Sc-8008) (Santa Cruz Biotechnologies) Paraoxonase 2 (PON2) (# SAB2700275). Actin, vinculin, and glyceraldehyde-3-phosphate dehydrogenase (GADPH) were used as normalizers.
+ Open protocol
+ Expand
2

Western Blot Analysis of MMP-2, NF-κB, and p38

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed as previously described [16 (link)]. Briefly, whole-cell lysates were prepared in lysis buffer (Cell Signaling Technology, MA, USA). Samples containing 30 μg of protein were resolved by electrophoresis gels and transferred to a nitrocellulose membrane. After blocking for 1h with 5% skim milk in PBST, membranes were incubated overnight at 4 °C with anti-MMP-2 (MAB902, R&D Systems; Minneapolis, MN, USA), NF-κB p65 (sc-8008, Santa Cruz Biotechnology, Dallas, TX, USA), p38 (D13E1-Cell Signaling Technology, MA, USA), phospho–p38 (D3F9-Cell Signaling Technology, MA, USA), and anti-β-actin (Millipore Corporation, Billerica, MA, USA) primary antibodies. Membranes were then probed with goat anti-mouse IgG-HRP (31430, Thermo Scientific) secondary antibody at room temperature (RT) for 1 h. Detection of the immunoreactive bands was performed using the Clarity Western ECL Substrate (BioRad). β-actin served as a loading control. Densitometric analysis was performed using Image J.
+ Open protocol
+ Expand
3

Monosodium Urate Crystal-Induced Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monosodium urate (MSU) crystals were obtained from InvivoGen (Carlsbad, CA, USA). Phorbol 12-myristate 13-acetate (PMA), colchicine, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO; ≥99.5%) were bought from Sigma-Aldrich (St. Louis, MO, USA). Antibodies for IL-1β (12242) and NLRP3 (15101) were purchased from Cell Signaling Technology (USA). Antibodies against caspase-1 (sc-56036), phospho-IκB-α (sc-52943) and NF-κB p65 (sc-8008) were from Santa Cruz Biotechnology (Dallas, TX, USA) and β-actin antibody was from Abcam (Cambridge, UK). Peroxidase-conjugated AffiniPure goat anti-mouse IgG (115-035-003), and anti-rabbit IgG HRP-linked antibody (7074) as secondary antibodies were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA) and Cell Signaling Technology, respectively.
+ Open protocol
+ Expand
4

Synthesis and Antibody Characterization of C-DIM12

Check if the same lab product or an alternative is used in the 5 most similar protocols
C-DIM12 was synthesized as described by Qin et al. (2004) (link). All general chemical reagents were purchased from Sigma, Aldrich (St. Louis, MO) unless stated otherwise. TNFα was purchased from R&D Systems (Minneapolis, MN). Specific primary antibodies against VCAM-1(55330), ICAM-1 (553253), Mac-1(Cd11b) (553310), CD90.2 (553011), COX-2 (610204) were purchased from BD Biosciences (San Jose, CA), antibodies against Nurr1 (SC-376984) and NF-κB p65 (SC-8008) were purchased from Santa Cruz Biotechnology (Dallas, TX), antibody against Vimentin (AB1620) was purchased from EMD Millipore (Burlington, MA), and Iκβα (4814) was purchased from Cell Signaling Technology (Danvers, MA).
+ Open protocol
+ Expand
5

Western Blot Analysis of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed as previously described (Fazzini et al., 2014 (link); Smoktunowicz et al., 2016 (link)). Proteins were quantified with the Bradford assay. Proteins were separated onto a pre-cast 4–20% polyacrylamide gel (Mini-PROTEAN® TGX gel, Biorad, Hercules, CA, United States) and transferred to PVDF membranes (Trans-Blot® TurboTM PVDF Transfer packs, Biorad, Hercules, CA, United States). Membranes were blocked with 3% BSA diluted in Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.5, 150 mM NaCl) with 0.1% Tween 20. Primary antibodies against β-actin (ab8227, Abcam, Cambridge, United Kingdom), nuclear factor-κB p65 (NF-κB p65, sc-8008, Santa Cruz, Dallas, United States) S100-β (ab52642, Abcam, Cambridge, United Kingdom) and TLR-4 (ab22048, Abcam, Cambridge, United Kingdom) were used. Secondary antibodies were obtained from Abcam (anti-mouse ab97040 and anti-rabbit ab6721). Protein bands were detected with ECL reagents (Clarity Western ECL Blotting Substrate, Biorad, Hercules, CA, United States). Densitometry was performed by IBright Analysis software.
+ Open protocol
+ Expand
6

Antibody Sourcing for Malaria Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against PKCζ (9372), MET (4560), AKT (9272s), phospho-AKT (9271), ERK1/2 (9102), and phospho-ERK (9101) were obtained from Cell Signaling. CXCR4 (60042–1-Ig), NGFR (55014–1-AP), KRBP (10386–1-AP), SULF2 (12260–1-AP), and dihydrofolate reductase (15194–1-AP) were obtained from Proteintech. Antibodies against CD160 (ab202845), C1orf114 (ab121933), and CTRP4 (ab36871) were obtained from Abcam. Anti-IκBα (sc-371) and NF-κB p65 (sc-8008) were obtained from Santa Cruz. Anti–β-actin antibody (A1978) was obtained from Sigma-Aldrich. Antibodies against Plasmodium UIS4 (LS-C204260/53255) and Plasmodium HSP70 (LS-C109068/25028) were obtained from LSBio. Anti-P. falciparum CSP (MRA-183A) was obtained from MR4. Polyclonal anti-UIS3 was raised in a rabbit against its recombinant protein, which was produced by the pET system (Clontech) in Escherichia coli. Anti-AMA1 was kindly provided by Prakash Srinivasan (Johns Hopkins Malaria Research Institute, Baltimore, MD). Recombinant human HGF (100-39) was obtained from Peprotech.
+ Open protocol
+ Expand
7

Quantification of Bioactive Compounds in PTH

Check if the same lab product or an alternative is used in the 5 most similar protocols
TAK-242 (HY-11109) was obtained from MedChemExpress (Monmouth Junction, NJ, USA). TLR4 (sc-293072), MyD88 (sc-74532), IκBα (sc-1643), and NF-κB p65 (sc-8008) primary antibodies were provided by Santa Cruz Biotechnology (Dallas, TX, USA). COX-2 (12282), GFAP (3670), p38 (8690), JNK (9252), ERK1/2 (9102), p-EEK1/2 (Thr202/Tyr204) (9101), and GAPDH (2118) primary antibodies were provided by Cell Signaling Technology (Danvers, MA, USA). iNOS (ab3523) and TNF receptor-associated factor 6 (TRAF6, ab33915) primary antibodies were provided by ABCAM (Cambridge, MA, USA). Each secondary antibody was provided by Thermo Fisher Scienti c (Rockland, IL, USA).
PTH capsules were purchased from Zhangzhou PTH Pharmaceutical Co., LTD. (Zhangzhou, China). In accordance with our reported UPLC-MS/MS method [22] , 21 characteristic compounds (taurine, malic acid, citric acid, cholic acid, hyodeoxycholic acid, ursodeoxycholic acid, chenodeoxycholic acid, taurocholic acid, taurochenodeoxycholic acid, tauroursodeoxycholic acid, glycodeoxycholic acid, glycocholic acid notoginsenoside R1, ginsenosides Rg1, Rb1, Re, Rf, Rd, Rg2, Rg3, Rh1, and muscone) in the PTH capsules were accurately quanti ed, and the total content of those compounds was 183.73 mg/g.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!